Use: Results are for the identification and differentiation of RNA from SARS-CoV-2, Influenza A, Influenza B and RSV.

Limitations: This assay is intended for use only under the Food and Drug Administration's Emergency Use Authorization.

Methodology:  Nucleic Acid Amplification (NAA)

***This test is only available to practitioners that collect specimens in office ***

Specimen: Anterior nasal swab; nasopharyngeal swab, mid-turbinate swab

Volume: 1 - 3 mL

Minimum Volume: 1 mL (Note: This volume does not allow for repeat testing.)

Container:  Anterior nasal swab, nasopharyngeal (NP) swab or mid-turbinate swab in viral/universal transport medium (VTM/UTM) or 0.9% saline

Collection: Nasopharyngeal (NP) and mid-turbinate swabs: Collect using standard techniques. Place the swab into VTM/UTM and cap tightly.

Anterior nasal swab: Insert the tip of the swab into one nostril. The swab does not need to be inserted far. Insert just until the tip of the swab is no longer visible. Rotate the swab in a circle around the entire edge of your nostril at least three times. Repeat with the second nostril. Insert swab into the 0.9% saline tube and cap tightly.

Storage Instructions: 

Frozen at -20° C (preferred). Refrigerated specimens and room temperature specimens (if received for testing within 72 hours of collection) are also acceptable.